Klintmalm Gb

499 total citations
25 papers, 370 citations indexed

About

Klintmalm Gb is a scholar working on Surgery, Transplantation and Hepatology. According to data from OpenAlex, Klintmalm Gb has authored 25 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 16 papers in Transplantation and 10 papers in Hepatology. Recurrent topics in Klintmalm Gb's work include Organ Transplantation Techniques and Outcomes (16 papers), Renal Transplantation Outcomes and Treatments (15 papers) and Liver Disease and Transplantation (9 papers). Klintmalm Gb is often cited by papers focused on Organ Transplantation Techniques and Outcomes (16 papers), Renal Transplantation Outcomes and Treatments (15 papers) and Liver Disease and Transplantation (9 papers). Klintmalm Gb collaborates with scholars based in United States and United Kingdom. Klintmalm Gb's co-authors include Abraham Shaked, Kenneth E. Drazan, Bo S. Husberg, Wiesner Rh, Harvey Solomon, Shaw Bw, Thomas A. Gonwa, John R. Lake, Robert J. Stratta and Robert M. Goldstein and has published in prestigious journals such as PubMed.

In The Last Decade

Klintmalm Gb

25 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klintmalm Gb United States 12 240 186 144 89 40 25 370
Gaëlle Dörr France 10 180 0.8× 198 1.1× 204 1.4× 45 0.5× 30 0.8× 12 401
Robert J. Stratta United States 10 200 0.8× 41 0.2× 134 0.9× 149 1.7× 21 0.5× 13 416
Koji Nanmoku Japan 12 135 0.6× 33 0.2× 183 1.3× 67 0.8× 84 2.1× 40 402
J.R. Fernández Spain 12 199 0.8× 216 1.2× 73 0.5× 129 1.4× 48 1.2× 21 376
Hakala Tr United States 10 214 0.9× 36 0.2× 229 1.6× 31 0.3× 82 2.0× 21 388
Ferguson Rm United States 11 167 0.7× 32 0.2× 157 1.1× 17 0.2× 63 1.6× 48 352
H. J. Schlitt Germany 7 177 0.7× 50 0.3× 89 0.6× 22 0.2× 32 0.8× 20 272
Janice L. Johnson United States 3 335 1.4× 19 0.1× 304 2.1× 73 0.8× 18 0.5× 3 447
Plamen Mihaylov United States 12 263 1.1× 238 1.3× 53 0.4× 102 1.1× 71 1.8× 44 393
M. S. A. Kumar United States 8 127 0.5× 16 0.1× 167 1.2× 63 0.7× 61 1.5× 29 266

Countries citing papers authored by Klintmalm Gb

Since Specialization
Citations

This map shows the geographic impact of Klintmalm Gb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klintmalm Gb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klintmalm Gb more than expected).

Fields of papers citing papers by Klintmalm Gb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klintmalm Gb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klintmalm Gb. The network helps show where Klintmalm Gb may publish in the future.

Co-authorship network of co-authors of Klintmalm Gb

This figure shows the co-authorship network connecting the top 25 collaborators of Klintmalm Gb. A scholar is included among the top collaborators of Klintmalm Gb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klintmalm Gb. Klintmalm Gb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gb, Klintmalm, et al.. (2016). Importance of Hepatic Flows in Liver Transplantation. 2(2). 9 indexed citations
2.
Gb, Klintmalm. (2000). [International registry of liver tumors in liver transplantation. A registry update on hepatocellular carcinoma (HCC)].. PubMed. 125(7). 642–6. 5 indexed citations
3.
Gb, Klintmalm, et al.. (1997). Immune reconstitution with donor-derived memory/effector T cells after orthotopic liver transplantation.. PubMed. 25(2). 147–59. 17 indexed citations
4.
Gb, Klintmalm. (1996). Clinical use of FK 506 in liver transplantation.. PubMed. 28(2). 974–6. 11 indexed citations
5.
Abbasoğlu, Osman, et al.. (1996). Adenovirus infection of the human intestinal allograft: a case report.. PubMed. 28(5). 2786–7. 4 indexed citations
6.
Gb, Klintmalm, et al.. (1995). Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.. PubMed. 27(1). 1114–6. 20 indexed citations
7.
Gb, Klintmalm, et al.. (1995). Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.. PubMed. 27(1). 1121–3. 36 indexed citations
8.
Gb, Klintmalm. (1994). FK 506: an update.. PubMed. 8(2 Pt 2). 207–10. 18 indexed citations
9.
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 641–3. 7 indexed citations
10.
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 635–7. 8 indexed citations
11.
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 679–88. 19 indexed citations
12.
Gb, Klintmalm, et al.. (1992). Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease.. PubMed. 24(1). 156–7. 13 indexed citations
13.
Shaked, Abraham, et al.. (1992). Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome.. PubMed. 174(6). 453–9. 65 indexed citations
14.
Solomon, Harvey, et al.. (1991). Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections.. PubMed. 23(1 Pt 2). 1528–30. 14 indexed citations
15.
Gb, Klintmalm, et al.. (1990). Problematic vascular reconstruction in liver transplantation. Part II. Portovenous conduits.. PubMed. 107(5). 544–8. 27 indexed citations
16.
Solomon, Harvey, et al.. (1990). Liver transplantation, 1990: a Dallas perspective.. PubMed. 123–33. 4 indexed citations
17.
Fehrman, I, et al.. (1988). A clear distinction between "immune activation of rejection" and "no immune activation" in liver transplant aspiration cytology.. PubMed. 20(4). 661–2. 3 indexed citations
18.
Gb, Klintmalm. (1988). The liver donor: special considerations.. PubMed. 20(5 Suppl 7). 9–11. 5 indexed citations
19.
Gb, Klintmalm, et al.. (1984). Human renal allograft blood flow, oxygen extraction, and prostaglandin release: their bearing on graft function.. PubMed. 95(4). 427–32. 3 indexed citations
20.
Te, Starzl, et al.. (1983). Steps in immunosuppression for renal transplantation.. PubMed. S–60. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026